Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study

Kunihiro Yamagata, Tomohiro Ohigashi, Chie Saito, Hirayasu Kai, Ryoya Tsunoda, Reiko Okubo, Masahide Kondo, Haruka Ishii, Masami Inuzuka, Kenji Harada, Ichiei Narita, Hirokazu Okada, Takashi Wada, Shoichi Maruyama, Junichi Hoshino

Open source

DOI: 10.1186/s12882-026-05036-3
Published: 2026-05-25
Container: BMC Nephrology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12882-026-05036-3,
  title = {Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study},
  author = {Kunihiro Yamagata and Tomohiro Ohigashi and Chie Saito and Hirayasu Kai and Ryoya Tsunoda and Reiko Okubo and Masahide Kondo and Haruka Ishii and Masami Inuzuka and Kenji Harada and Ichiei Narita and Hirokazu Okada and Takashi Wada and Shoichi Maruyama and Junichi Hoshino},
  year = {2026},
  journal = {BMC Nephrology},
  doi = {10.1186/s12882-026-05036-3},
  url = {https://doi.org/10.1186/s12882-026-05036-3}
}

RIS

TY  - JOUR
TI  - Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study
AU  - Kunihiro Yamagata
AU  - Tomohiro Ohigashi
AU  - Chie Saito
AU  - Hirayasu Kai
AU  - Ryoya Tsunoda
AU  - Reiko Okubo
AU  - Masahide Kondo
AU  - Haruka Ishii
AU  - Masami Inuzuka
AU  - Kenji Harada
AU  - Ichiei Narita
AU  - Hirokazu Okada
AU  - Takashi Wada
AU  - Shoichi Maruyama
AU  - Junichi Hoshino
PY  - 2026
JO  - BMC Nephrology
DO  - 10.1186/s12882-026-05036-3
UR  - https://doi.org/10.1186/s12882-026-05036-3
ER  -

APA

Yamagata, K., Ohigashi, T., Saito, C., Kai, H., Tsunoda, R., Okubo, R., Kondo, M., Ishii, H., Inuzuka, M., Harada, K., Narita, I., Okada, H., Wada, T., Maruyama, S., & Hoshino, J. (2026). Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study. BMC Nephrology. https://doi.org/10.1186/s12882-026-05036-3

Source records

crossref · retrieved 2026-09-26T12:33:05.210Z